Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Wael Sumaya, William A.E. Parker, Heather M. Judge, Ian R. Hall, Rachel C. Orme, Zulfiquar Adam, James D. Richardson, Alexander M.K. Rothman, Kenneth P. Morgan, Julian P. Gunn & Robert F. Storey. (2021) Prolonged enoxaparin therapy compared with standard-of-care antithrombotic therapy in opiate-treated patients undergoing primary percutaneous coronary intervention. Platelets 32:4, pages 555-559.
Read now
Read now
William A. E. Parker & Robert F. Storey. (2021) Novel approaches to P2Y12 inhibition and aspirin dosing. Platelets 32:1, pages 7-14.
Read now
Read now
William A.E. Parker, Rachel C. Orme, Jessica Hanson, Hannah M. Stokes, Claire M. Bridge, Patricia A. Shaw, Wael Sumaya, Kirstie Thorneycroft, Giovanna Petrucci, Benedetta Porro, Heather M. Judge, Ramzi A. Ajjan, Bianca Rocca & Robert F. Storey. (2019) Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome. Platelets 30:2, pages 148-157.
Read now
Read now
Rebecca Gosling, Momina Yazdani, Yasir Parviz, Ian R Hall, Ever D. Grech, Julian P Gunn, Robert F. Storey & Javaid Iqbal. (2017) Comparison of P2Y12 inhibitors for mortality and stent thrombosis in patients with acute coronary syndromes: Single center study of 10 793 consecutive ‘real-world’ patients. Platelets 28:8, pages 767-773.
Read now
Read now
Articles from other publishers (7)
William AE Parker & Robert F Storey. (2021) Antithrombotic therapy for patients with chronic coronary syndromes. Heart 107:11, pages 925-933.
Crossref
Crossref
Thomas W. Johnson, Sarah Baos, Laura Collett, James L. Hutchinson, Martin Nkau, Maria Molina, Riyaad Aungraheeta, Christopher Reilly‐Stitt, Ruth Bowles, Barnaby C. Reeves, Chris A. Rogers, Stuart J Mundell, Andreas Baumbach & Andrew D. Mumford. (2020) Pharmacodynamic Comparison of Ticagrelor Monotherapy Versus Ticagrelor and Aspirin in Patients After Percutaneous Coronary Intervention: The TEMPLATE (Ticagrelor Monotherapy and Platelet Reactivity) Randomized Controlled Trial. Journal of the American Heart Association 9:24.
Crossref
Crossref
William A. E. Parker, Christian Schulte, Temo Barwari, Fladia Phoenix, Sam M. Pearson, Manuel Mayr, Peter J. Grant, Robert F. Storey & Ramzi A. Ajjan. (2020) Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels. Cardiovascular Diabetology 19:1.
Crossref
Crossref
Gerasimos Siasos, Vasiliki Tsigkou, Evangelos Oikonomou, Marina Zaromitidou & Dimitris Tousoulis. 2018. Coronary Artery Disease. Coronary Artery Disease
391
415
.
Thea C. Godschalk, Laura M. Willemsen, Bastiaan Zwart, Thomas O. Bergmeijer, Paul Willem A. Janssen, Johannes C. Kelder, Christian M. Hackeng & Jurriën M. ten Berg. (2017) Effect of Tailored Antiplatelet Therapy to Reduce Recurrent Stent Thrombosis and Cardiac Death After a First Episode of Stent Thrombosis. The American Journal of Cardiology 119:10, pages 1500-1506.
Crossref
Crossref
William A. E. Parker & Robert F. Storey. (2016) Ticagrelor: agonising over its mechanisms of action. Blood 128:23, pages 2595-2597.
Crossref
Crossref
Dorothee KaudewitzPhilipp SkroblinLukas H. BenderTemo BarwariPeter WilleitRaimund PechlanerNicholas P. SunderlandKarin WilleitAllison C. MortonPaul C. ArmstrongMelissa V. ChanRuifang LuXiaoke YinFilipe GracioKatarzyna DudekSarah R. LangleyAnna ZampetakiEmanuele de RinaldisShu YeTimothy D. WarnerAlka SaxenaStefan KiechlRobert F. StoreyManuel Mayr. (2016) Association of MicroRNAs and YRNAs With Platelet Function. Circulation Research 118:3, pages 420-432.
Crossref
Crossref